These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38298652)

  • 21. Green bonds issuance, innovation performance, and corporate value: Empirical evidence from China.
    Khurram MU; Xie W; Mirza SS; Tong H
    Heliyon; 2023 Apr; 9(4):e14895. PubMed ID: 37025905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shareholder personal risk and firm risk: An empirical analysis of share pledges and firm debt policies.
    Xia J; Wu Z; Zhang R; Chen X; Zhang R
    Front Psychol; 2022; 13():1010162. PubMed ID: 36467181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Market expectations, learning effect and the termination of employee stock ownership plan.
    Zhou H
    Heliyon; 2023 Mar; 9(3):e14602. PubMed ID: 36967969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the opening of high-speed rail on corporate financing constraints.
    Liao Y; Qiu X; Sun Q; Li P
    PLoS One; 2022; 17(6):e0268994. PubMed ID: 35666715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corporate immunity to the COVID-19 pandemic.
    Ding W; Levine R; Lin C; Xie W
    J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital finance and Chinese corporate labor investment efficiency: The perspective of financing constraints and human capital structure.
    Yang J; Jiang Y; Chen H; Gan S
    Front Psychol; 2022; 13():962806. PubMed ID: 36033042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does green credit policy affect corporate innovation performance?-A quasi-natural experiment based on Green Credit Guidelines.
    Wu J; Tang Q; Yang Y
    PLoS One; 2023; 18(10):e0291764. PubMed ID: 37792738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M&A goodwill and corporate technological innovation: The mediating moderating effect of stock pledges.
    Zhang Y; Sun Z; Zhou Y; Dong Y
    PLoS One; 2022; 17(8):e0271214. PubMed ID: 36037164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Managerial Reputation and Risk-Taking on Enterprise Innovation Investment From the Perspective of Social Capital: Evidence From China.
    Wang S; Zhao S; Shao D; Fan X; Zhang B
    Front Psychol; 2022; 13():931227. PubMed ID: 35874409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon emission trading scheme and corporate labor investment efficiency: evidence from China.
    Ma J; Xiang Y; Bai X
    Environ Sci Pollut Res Int; 2023 Aug; 30(39):90830-90843. PubMed ID: 37462874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting and inhibiting: Corporate charitable donations and innovation investment under different motivation orientations--Evidence from Chinese listed companies.
    Wang H; Zhang Y; Tian M; Wang Z; Ding Y
    PLoS One; 2022; 17(4):e0266199. PubMed ID: 35417498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Environmental Regulation Reduce Labor Costs and Improve Business Performance? Evidence From the Air Quality Index.
    Chai KC; Huang Y; Chang KC; Hu WJ
    Front Public Health; 2019; 7():398. PubMed ID: 32010654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of executive compensation incentive on corporate innovation capability: Evidence from agro-based companies in China.
    Shang Y; Xu J; Li J
    PLoS One; 2023; 18(9):e0291517. PubMed ID: 37699045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of CEO tenure on corporate social and environmental performance: an emerging country's analysis.
    Khan TM; Gang B; Fareed Z; Yasmeen R
    Environ Sci Pollut Res Int; 2020 Jun; 27(16):19314-19326. PubMed ID: 32212078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altruistic motivation or instrumental motivation: The spatial spillover effect of corporate social responsibility on corporate green innovation.
    Chen D; Peng Z
    PLoS One; 2023; 18(10):e0290125. PubMed ID: 37856561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How does CEO tenure affect corporate social and environmental disclosures in China? Moderating role of information intermediaries and independent board.
    Khan TM; Gang B; Fareed Z; Khan A
    Environ Sci Pollut Res Int; 2021 Feb; 28(8):9204-9220. PubMed ID: 33131043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does digital finance promote corporate social responsibility of pollution-intensive industry? Evidence from Chinese listed companies.
    Xin D; Yi Y; Du J
    Environ Sci Pollut Res Int; 2022 Dec; 29(56):85143-85159. PubMed ID: 35790640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of tax reduction on enterprises' financialization-A quasi-natural experiment based on the reduction of VAT rate.
    Duan S; Lu Y; Cheng Y; Liu Q
    PLoS One; 2023; 18(12):e0293385. PubMed ID: 38128033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.